Key Takeaways
- • PTA Partners secures controlling stake in French cosmetics manufacturer: Seoul-based private equity firm PTA Partners has signed a memorandum of understanding to acquire a 70% stake in COSBELLE, a French organic and premium cosmetics ODM (original development manufacturer), valued at approximately 60 billion won ($46 million USD equivalent).
- • First Korean PE-backed management control of French cosmetics manufacturer: This transaction marks the inaugural instance of Korean private equity capital acquiring management control of a cosmetics manufacturing company in France, establishing a K-beauty production foothold in the European luxury cosmetics heartland.
- • Competitive bidding process with major Korean ODM participation: COSBELLE attracted significant interest from Korean strategic and financial investors, including domestic ODM leaders Cosmax, Cosmecca Korea, Kolmar Korea, and Goodai Global, with at least one competitor conducting on-site due diligence before PTA prevailed with its value-creation strategy.
- • Planned follow-on investment and institutional LP fundraising: PTA intends to deploy an additional 10 billion won in capital and is establishing a project fund of at least 50 billion won, with imminent marketing efforts targeting major domestic institutional investors to support growth initiatives.
- • Strategic positioning within broader K-beauty PE boom: The acquisition reflects accelerating private equity interest in South Korean cosmetics companies, driven by robust global demand for K-beauty products, particularly in the US and European markets where Korean brands have achieved viral commercial success.
Summary
PTA Partners, a Seoul-based mid-market private equity firm led by France-born CEO Kim Seok-won, has secured preferred bidder status and signed a memorandum of understanding to acquire a 70% controlling stake in COSBELLE, a French organic and premium cosmetics original development manufacturer. The transaction values COSBELLE at approximately 60 billion won and represents the first instance of Korean private equity capital obtaining management control of a cosmetics manufacturing company in France—a strategically significant milestone given France's position as a global luxury beauty hub.
COSBELLE, founded in 1971, has established deep technical expertise in organic and natural cosmetics manufacturing. The company underwent a management spin-off in 2019, after which current ownership elevated technological capabilities and operational scale. The acquisition drew intense bidding competition from major Korean market participants, including strategic investors such as Cosmax and Cosmecca Korea, as well as financial investors including Kolmar Korea and Goodai Global. At least one competing bidder advanced to on-site due diligence at the French facility, underscoring the transaction's competitive profile. PTA prevailed by presenting what investment banking sources characterize as the most concrete value-creation strategy, with Kim Seok-won's established local networks in France providing additional competitive advantage.
Beyond the 70% controlling stake acquisition, PTA plans to deploy an additional 10 billion won in capital for growth initiatives. To fund the transaction and expansion, PTA is establishing a dedicated project fund capitalized at a minimum of 50 billion won and will immediately commence marketing efforts to major domestic institutional investors (LPs) to complete capitalization.
This transaction exemplifies accelerating private equity appetite for South Korean cosmetics companies. Recent comparable activity includes Bain Capital Private Equity's acquisition of majority stake in Carver Korea Co. (valued at approximately $675 million) and Amorepacific's 2023 acquisition of COSRX, which generated nearly 60% of revenues from US and European markets, driven by viral commercial success. South Korea's three largest contract manufacturers—Cosmax, Korea Kolmar, and Cosmecca—have collectively been approached by foreign investors regarding acquisition opportunities, reflecting institutional conviction in the K-beauty market's secular growth trajectory.
COSBELLE, founded in 1971, has established deep technical expertise in organic and natural cosmetics manufacturing. The company underwent a management spin-off in 2019, after which current ownership elevated technological capabilities and operational scale. The acquisition drew intense bidding competition from major Korean market participants, including strategic investors such as Cosmax and Cosmecca Korea, as well as financial investors including Kolmar Korea and Goodai Global. At least one competing bidder advanced to on-site due diligence at the French facility, underscoring the transaction's competitive profile. PTA prevailed by presenting what investment banking sources characterize as the most concrete value-creation strategy, with Kim Seok-won's established local networks in France providing additional competitive advantage.
Beyond the 70% controlling stake acquisition, PTA plans to deploy an additional 10 billion won in capital for growth initiatives. To fund the transaction and expansion, PTA is establishing a dedicated project fund capitalized at a minimum of 50 billion won and will immediately commence marketing efforts to major domestic institutional investors (LPs) to complete capitalization.
This transaction exemplifies accelerating private equity appetite for South Korean cosmetics companies. Recent comparable activity includes Bain Capital Private Equity's acquisition of majority stake in Carver Korea Co. (valued at approximately $675 million) and Amorepacific's 2023 acquisition of COSRX, which generated nearly 60% of revenues from US and European markets, driven by viral commercial success. South Korea's three largest contract manufacturers—Cosmax, Korea Kolmar, and Cosmecca—have collectively been approached by foreign investors regarding acquisition opportunities, reflecting institutional conviction in the K-beauty market's secular growth trajectory.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.